CLINICAL_TRIALS
trial_result
· 2021-02-25
Clinical Trial Update: Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics [Phase 4]
Summary
A Phase 4 trial assessing the effectiveness of liraglutide added to high-dose insulin in patients with type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mountain Diabetes and Endocrine Center | Conditions: Diabetes Mellitus, Type II | Phase 4 | Status: COMPLETED